A combination of the appropriate epilepsy service and modern methods of microneurosurgery allow realization of an effective high technology medical care to patients with symptomatic temporal epilepsy.
Objective: to establish the relationship between the presence of cognitive disorders in patients with arterial hypertension and changes in EEG, to assess the dynamics of these changes against the background of various modes of cerebroprotective therapy.Materials and methods: the study involved 92 people with arterial hypertension, whose average age was 63 ± 8.2 years. The research was carried out on the device “Encephalan-EEGR-19/26”. To assess cognitive functions, patients were tested using the MoСA test. Patients with cognitive impairment were divided into three groups of dynamic monitoring with diff erent modes of cerebroprotective therapy.Results: non-specifi c patterns in the slow-wave range were registered in patients with cognitive impairment during visual EEG analysis. In the quantitative analysis of the EEG revealed changes in the frequency and amplitude of the alpha rhythm, the power variation on the basic rhythms, the reduction of the total strength of the rhythms, the increase in relative power of slow rhythms in the frontal leads to the total power of the rhythms. After the treatment, most patients showed an increase in scores on the “Montreal scale”, a decrease in anxiety and depression on the” Hospital scale”, and an increase in the SF-36 index. Quantitative EEG analysis revealed positive dynamics comparable to the clinic and test data. The most favorable EEG dynamics was registered in groups of patients receiving neuroprotective and combined therapy.Conclusions: the results obtained indicate the diagnostic value of quantitative EEG analysis and the feasibility of adding drugs that improve the metabolism and blood supply to the brain to standard antihypertensive therapy.
The article is devoted to an urgent problem – cognitive impairment in patients with arterial hypertension. The aim of the study was to establish objective qualitative and quantitative EEG criteria for cognitive impairment in patients with hypertension in order to use them later to determine the optimal regimen of cerebroprotective therapy and evaluate its effectiveness. The study involved 192 people (patients with hypertension and potentially healthy people without hypertension and CN). The number of patients with an established diagnosis of AH and with CN was 99 people. They were divided into three groups in accordance with the regimens of cerebroprotective therapy prescribed by the neurologist. As a result of the work, an algorithm of treatment tactics was developed and an application for patent No. 2021126327, priority date 06.09.2021, was issued.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.